← back to search

Kim De Keersmaecker

KU Leuven · BE
Area of research
Public Health, Environmental and Occupational Health · Hematology
Research interest
Research focused on Cancer research and CDKN2A, with related work in Epigenetics, Ribosomal protein, PRC2. Notable publications include 'Genetic inactivation of the polycomb repressive complex 2 in T cell acute lymphoblastic leukemia', 'Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia', and 'The genetics and molecular biology of T-ALL'.
h-index
citations
3,576
works
28
NIH funding
primary concept
email

Recent publications

HNRNPC and m6A RNA methylation control oncogenic transcription and metabolism in T-cell leukemia
Blood 2025cited by 12position: middledoi
Transcription factor NKX2–1 drives serine and glycine synthesis addiction in cancer
British Journal of Cancer 2023cited by 35position: middledoi
Targeting serine/glycine metabolism improves radiotherapy response in non-small cell lung cancer
British Journal of Cancer 2023cited by 22position: middledoi
Optimizing the diagnostic workflow for acute lymphoblastic leukemia by optical genome mapping
American Journal of Hematology 2022cited by 71position: middledoi
<i>HEATR3</i> variants impair nuclear import of uL18 (RPL5) and drive Diamond-Blackfan anemia
Blood 2022cited by 39position: middledoi
The ins and outs of serine and glycine metabolism in cancer
Nature Metabolism 2021cited by 237position: middledoi
14q32 rearrangements deregulating <i>BCL11B </i>mark a distinct subgroup of T and myeloid immature acute leukemia
Blood 2021cited by 40position: middledoi
Repurposing the Antidepressant Sertraline as SHMT Inhibitor to Suppress Serine/Glycine Synthesis–Addicted Breast Tumor Growth
Molecular Cancer Therapeutics 2020cited by 83position: lastdoi
Single-cell DNA amplicon sequencing reveals clonal heterogeneity and evolution in T-cell acute lymphoblastic leukemia
Blood 2020cited by 68position: middledoi
Hallmarks of ribosomopathies
Nucleic Acids Research 2019cited by 193position: lastdoi
Translatome analysis reveals altered serine and glycine metabolism in T-cell acute lymphoblastic leukemia cells
Nature Communications 2019cited by 105position: lastdoi
Cancer Biogenesis in Ribosomopathies
Cells 2019cited by 84position: lastdoi
Single-cell sequencing reveals the origin and the order of mutation acquisition in T-cell acute lymphoblastic leukemia
Leukemia 2018cited by 85position: middledoi
The ribosomal RPL10 R98S mutation drives IRES-dependent BCL-2 translation in T-ALL
Leukemia 2018cited by 73position: lastdoi
The genetics and molecular biology of T-ALL
Blood 2017cited by 354position: lastdoi
The ribosomal protein gene RPL5 is a haploinsufficient tumor suppressor in multiple cancer types
Oncotarget 2017cited by 123position: lastdoi
The T-cell leukemia-associated ribosomal RPL10 R98S mutation enhances JAK-STAT signaling
Leukemia 2017cited by 79position: lastdoi
Synergistic antileukemic therapies in <i>NOTCH1</i> -induced T-ALL
Proceedings of the National Academy of Sciences 2017cited by 62position: middledoi
Ribosomopathies and the paradox of cellular hypo- to hyperproliferation
Blood 2015cited by 111position: firstdoi
Bypass of the pre-60S ribosomal quality control as a pathway to oncogenesis
Proceedings of the National Academy of Sciences 2014cited by 80position: middledoi
Prognostic relevance of integrated genetic profiling in adult T-cell acute lymphoblastic leukemia
Blood 2013cited by 149position: middledoi
Comprehensive Analysis of Transcriptome Variation Uncovers Known and Novel Driver Events in T-Cell Acute Lymphoblastic Leukemia
PLoS Genetics 2013cited by 137position: middledoi
NUP214-ABL1-mediated cell proliferation in T-cell acute lymphoblastic leukemia is dependent on the LCK kinase and various interacting proteins
Haematologica 2013cited by 47position: firstdoi
Genetic inactivation of the polycomb repressive complex 2 in T cell acute lymphoblastic leukemia
Nature Medicine 2012cited by 526position: middledoi
Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia
Nature Genetics 2012cited by 429position: firstdoi
Reverse engineering of TLX oncogenic transcriptional networks identifies RUNX1 as tumor suppressor in T-ALL
Nature Medicine 2012cited by 153position: middledoi
Mutation of the receptor tyrosine phosphatase PTPRC (CD45) in T-cell acute lymphoblastic leukemia
Blood 2012cited by 116position: middledoi
High Accuracy Mutation Detection in Leukemia on a Selected Panel of Cancer Genes
PLoS ONE 2012cited by 63position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jan Cools · KU Leuven12 papers (2012–2023)Kim R. Kampen · KU Leuven10 papers (2017–2023)Sergey O. Sulima · KU Leuven7 papers (2014–2019)Anne Uyttebroeck · KU Leuven7 papers (2012–2023)Tiziana Girardi · KU Leuven6 papers (2013–2019)Peter Vandenberghe · Memorial Sloan Kettering Cancer Center5 papers (2012–2021)Stijn Vereecke · KU Leuven5 papers (2017–2020)Ellen Geerdens · KU Leuven5 papers (2012–2018)Jelle Verbeeck · KU Leuven4 papers (2017–2023)Elien Heylen · KU Leuven4 papers (2020–2023)Heidi Segers · KU Leuven4 papers (2018–2023)Joyce Op de Beeck · KU Leuven4 papers (2013–2019)Michaël Porcu · KU Leuven3 papers (2012–2013)Elisabeth Paietta · Dana-Farber Cancer Institute3 papers (2012–2017)Christine J. Harrison · Newcastle University3 papers (2017–2021)Valentina Gianfelici · KU Leuven3 papers (2012–2013)Stein Aerts · VIB-KU Leuven Center for Cancer Biology3 papers (2012–2021)Lucienne Michaux · KU Leuven3 papers (2018–2022)Jonathan Royaert · KU Leuven3 papers (2017–2023)Jolien De Bie · KU Leuven3 papers (2018–2022)